adjuv chemotherapi vincristin ccnu patient duke colorect cancer swedish gastrointestin tumour adjuv therapi group prospect random trial adjuv postop combin chemotherapi lomustin ccnu vincristin versu adjuv therapi patient duke colorect cancer total patient year patient colon rectal cancer protocol violat case consider twenty-seven patient limit resect cancer year follow-up signific differ tumour-fre surviv rate surviv rate treat control group twenty-nin patient chemotherapi treatment side-effect gastrointestin tract patient treatment recurr diseas conclus system administr combin chemotherapi colorect cancer oper worthwhil routin clinic practic 